Market Cap | 6.05B | P/E | 39.12 | EPS this Y | -17.60% | Ern Qtrly Grth | -53.60% |
Income | 211.31M | Forward P/E | 27.57 | EPS next Y | 14.80% | 50D Avg Chg | 8.00% |
Sales | 4.59B | PEG | 2.47 | EPS past 5Y | 67.47% | 200D Avg Chg | 10.00% |
Dividend | N/A | Price/Book | 4.10 | EPS next 5Y | 10.00% | 52W High Chg | -6.00% |
Recommedations | 1.60 | Quick Ratio | 1.29 | Shares Outstanding | 171.02M | 52W Low Chg | 39.00% |
Insider Own | 0.52% | ROA | 5.91% | Shares Float | 170.05M | Beta | 1.29 |
Inst Own | 103.22% | ROE | 14.64% | Shares Shorted/Prior | 6.49M/5.88M | Price | 33.64 |
Gross Margin | 21.55% | Profit Margin | 4.60% | Avg. Volume | 3,738,012 | Target Price | 39.38 |
Oper. Margin | 6.57% | Earnings Date | Oct 23 | Volume | 1,898,604 | Change | -0.27% |
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
JMP Securities | Market Outperform | Sep 30, 24 |
Barrington Research | Outperform | Aug 1, 24 |
Barrington Research | Outperform | Jul 25, 24 |
JMP Securities | Market Outperform | Jul 16, 24 |
Barrington Research | Outperform | Apr 24, 24 |
Jefferies | Buy | Mar 4, 24 |
Barrington Research | Outperform | Feb 23, 24 |
Barrington Research | Outperform | Oct 26, 23 |
JP Morgan | Overweight | Oct 18, 23 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Bierbower Elizabeth D | Director Director | Oct 30 | Buy | 26.37 | 3,000 | 79,110 | 13,515 | 11/01/23 |
Pate R Carter | Director Director | Aug 06 | Buy | 34.32 | 1,465 | 50,279 | 106,112 | 08/21/23 |
KRAEMER HARRY M JANSEN JR | Director Director | Aug 11 | Buy | 34.6276 | 55,000 | 1,904,518 | 234,528 | 08/15/23 |
Smyser Collin | GC & Corporate Secre.. GC & Corporate Secretary | Aug 14 | Buy | 34.69 | 2,500 | 86,725 | 2,500 | 08/15/23 |
Bavaro Michael | Chief Human Resource.. Chief Human Resources Officer | Mar 10 | Sell | 31.45 | 6,148 | 193,355 | 21,549 | 03/14/23 |
Bavaro Michael | Chief Human Resource.. Chief Human Resources Officer | Mar 10 | Option | 21.47 | 4,605 | 98,869 | 27,697 | 03/14/23 |
Pate R Carter | Director Director | Oct 03 | Sell | 31.97 | 1,928 | 61,638 | 95,530 | 10/05/22 |
Walgreens Boots Alliance, Inc. | 10% Owner 10% Owner | Aug 16 | Sell | 33.01 | 11,000,000 | 363,110,000 | 26,247,092 | 08/18/22 |
Pate R Carter | Director Director | Aug 01 | Sell | 33.37 | 1,923 | 64,171 | 99,381 | 08/03/22 |
Pate R Carter | Director Director | Jul 08 | Sell | 30 | 1,923 | 57,690 | 101,304 | 07/12/22 |
Booker Harriet | CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER | Jun 06 | Option | 10.12 | 5,249 | 53,120 | 86,760 | 06/08/22 |
Booker Harriet | CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER | Jun 06 | Sell | 30.25 | 6,000 | 181,500 | 80,760 | 06/08/22 |
Pate R Carter | Director Director | Dec 21 | Sell | 28.77 | 7,048 | 202,771 | 107,070 | 06/03/22 |
Booker Harriet | CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER | Mar 07 | Option | 10.12 | 6,000 | 60,720 | 105,797 | 03/09/22 |
Booker Harriet | CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER | Mar 07 | Sell | 26.12 | 6,000 | 156,720 | 99,797 | 03/09/22 |
Booker Harriet | CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER | Nov 08 | Sell | 26.37 | 12,000 | 316,440 | 125,974 | 12/08/21 |
SULLIVAN TIMOTHY P | Director Director | Dec 29 | Sell | 15 | 600,000 | 9,000,000 | 114,265,391 | 12/29/20 |